AGRX - Agile Therapeutics EPS beats by $0.03 misses on revenue
Agile Therapeutics (AGRX): Q4 GAAP EPS of -$0.20 beats by $0.03.Revenue of $0.75M misses by $0.26M.Cash, cash equivalents and marketable securities of $54.5M.Shares +3.3%.Press Release
For further details see:
Agile Therapeutics EPS beats by $0.03, misses on revenue